How do you prepare a med spa for sale?
Start 24 to 36 months before you talk to a buyer, which is when CT Acquisitions says the owners who get top-quartile multiples begin. The financial work comes first: move the books to accrual, track prepaid packages, memberships and gift cards as deferred revenue, document every add-back as it happens, and get a monthly service-line P&L. Then cut the business's dependence on you and on any single injector, fix the medical director and ownership structure, and run a sell-side quality of earnings in the final year.
Want this answered for your own clinic?
Definition
Preparing a med spa for sale means getting the business into the shape a buyer's diligence will test: books a quality of earnings can confirm, earnings that do not depend on the owner or one provider, and a legal structure that holds up in every state the spa operates in.
The detail
Buyers value a med spa on adjusted EBITDA, and the AmSpa article on selling a medical spa (written by Maven Financial Partners) says the first step is a thorough evaluation of the business on financial metrics, with books that are accurate and kept up to date. Everything else in exit preparation is about making that EBITDA number larger and harder to argue with.
The books come first because they decide what the buyer believes. CT Acquisitions' 2026 exit playbook puts the switch from cash to accrual accounting at the very start of its timeline. Med spas sell prepaid packages, memberships and gift cards, and when that cash is booked as revenue the day it is collected, the buyer's quality of earnings reclassifies it as deferred revenue and lowers the EBITDA you take to market. CT Acquisitions estimates that poorly managed deferred revenue can cost 3% to 8% of enterprise value at close in med spa deals. The same playbook asks for a monthly close within 15 days and a service-line P&L every month, so injectables, lasers, skincare retail and memberships each show their own margin.
Add-backs are where clean books pay for themselves. An add-back is a cost that a buyer agrees will not continue after the sale, such as owner pay above what a replacement would cost, personal expenses run through the business, or related-party rent above market. CT Acquisitions' example: on a 6x multiple, $100,000 of clean, documented add-backs is $600,000 of sale price. Add-backs that are reconstructed at the end, without documentation, are the ones a buyer rejects, which is why the playbook says to tag each one as it happens, starting now.
Then the business has to run without you. CT Acquisitions calls provider concentration the lead key-person risk in med spa deals and sets a target of no single injector above 25% of injectable revenue. By the final year it wants the owner below 20% of injectable revenue, a general manager in place for at least 12 months before the sale, and written medical director and ownership (MSO and PC) arrangements in every operating state, checked by healthcare counsel. The legal structure is the counsel's job; making the numbers show that the spa no longer depends on one person is the finance job.
If you have 18 months rather than 36, the order does not change, only the overlap. Fix the accounting basis and deferred revenue first, because a buyer will look at trailing twelve-month results and every month you wait is a month on the old basis. Start the add-back schedule and the service-line P&L in the same month, move patients from your own schedule to other injectors, and plan the sell-side quality of earnings for the last six months. On who to sell to, AmSpa's article separates financial buyers, often private equity firms that aim to sell the practice again within three to seven years, from strategic buyers, which it says will often pay a higher price because they can fold the practice into an existing business and hold it for the long term. For what the finished business may be worth, see what a med spa is worth.
| When | Financial work | Operating work |
|---|---|---|
| 36 months out | Switch to accrual; align revenue and prepaid package amortization to ASC 606; start tagging every add-back | Written medical director agreement at a fair-market fee; MSO/PC structure reviewed by healthcare counsel |
| 24 months out | Monthly close in 15 days; service-line P&L every month; add-back schedule kept as a living document | Hire or promote a general manager; add W-2 injectors to spread provider concentration; membership push |
| 12 months out | Run a sell-side quality of earnings; isolate deferred revenue by source; clean A/R | Owner under 20% of injectable revenue; no single injector above 25% |
Summarized from CT Acquisitions' 2026 med spa exit playbook. The order matters more than the exact month.
Owners who get top-quartile multiples start preparing 24 to 36 months before they talk to a buyer.
Source: CT Acquisitions: Sell Your Med Spa, 2026 Exit Prep Playbook
On a 6x multiple, $100,000 of clean, documented add-backs is $600,000 of sale price.
Source: CT Acquisitions: Sell Your Med Spa, 2026 Exit Prep Playbook
Poorly managed deferred revenue can cost 3% to 8% of enterprise value at close in med spa deals.
Source: CT Acquisitions: Sell Your Med Spa, 2026 Exit Prep Playbook (estimate)
Target: no single injector above 25% of injectable revenue; owner under 20% in the final year.
Source: CT Acquisitions: Sell Your Med Spa, 2026 Exit Prep Playbook
Financial buyers, often private equity, typically aim to sell again within three to seven years.
Source: AmSpa: Selling Your Medical Spa (by Maven Financial Partners, November 2023)
What this means for clinic owners
From Sorso
For an owner 18 months from a sale, the first two months decide the most: the accounting basis, deferred revenue and the add-back schedule all have to be right before the trailing twelve months a buyer will test. That is finance work rather than broker work, and it is what a fractional CFO for med spas does before you hire a broker. A quality of earnings at the end then confirms the number instead of cutting it.
Talk it through
Want Stan to look at this for your clinic?
Stan Sukhinin, CFA, founded Sorso in 2020: a fractional CFO and accounting firm for outpatient clinics across the US, with accounting from $2,000 a month and fractional CFO from $4,000. Book a free 30-minute call, bring the question and, if you have it, last month's P&L, and he will tell you what he would check first.
Continue with Sorso
How clinic owners typically work with us after a question like this
Med Spa Accounting & CFO
Built for med spa economics
Injectable and device margins, membership revenue, and cash-pay mix — for med spa owners. From $2,000/mo.
Explore your specialty →Accounting
Healthcare-specialist accounting
Books done right by people who understand clinic finance. Starts at $2,000/mo.
Explore Accounting →Free Assessment
See where your clinic stands
4-minute, 15-question diagnostic. Personalized scorecard emailed to you.
Take the Free Assessment →Related questions
What is a med spa worth?
A med spa (medspa) typically sells for 3x to 6x EBITDA when it is small (typically under $5M of revenue) and 5x to 8x at $5M to $20M of revenue, according to Scope Research's 2026 med spa update. Regional chains above $20M of revenue reach 7x to 12x, and high-growth national platforms 10x to 20x. Buyers pay more for repeat-client revenue, a recognized brand and scale, and less for a spa that depends on its owner.
What are EBITDA add-backs in practice valuation?
EBITDA add-backs are non-recurring or owner-related expenses added back to reported EBITDA to show normalized earnings, the figure a buyer applies its multiple to. In an owner-operated practice they usually cover above-market owner pay, personal expenses run through the business, one-time costs and pro forma adjustments, and each one needs documents to survive a buyer's diligence.
Should I sell my practice to private equity?
Selling to private equity makes sense if you want partial liquidity, want to grow with capital and infrastructure, and are willing to operate as a partner rather than sole owner; it is wrong if you want full retirement or full operational autonomy.
What is a quality of earnings report?
A quality of earnings (QoE) report is a financial due diligence analysis, usually commissioned by the buyer, that normalizes EBITDA, tests whether revenue and expenses are reliable, and flags risks that affect the purchase price. Breakwater M&A puts the fee at $10,000 to $25,000 for a business with under $1M of EBITDA, rising to $50,000 to $150,000 at $10M to $25M.
How much does a quality of earnings report cost for a medical practice?
A quality of earnings (QoE) report for a medical practice typically costs $10,000 to $75,000 for practices with under $10M of EBITDA, based on Breakwater M&A's published fees: $10,000 to $25,000 under $1M of EBITDA, $15,000 to $40,000 at $1M to $3M, and $25,000 to $75,000 at $3M to $10M. Larger groups with $10M to $25M of EBITDA pay $50,000 to $150,000. A sell-side report typically costs 10 to 20 percent less than a buy-side one, and Breakwater's figures cover businesses generally, not healthcare specifically.
Founder of Sorso and a CFA charterholder. Before Sorso, Stan spent 19 years in corporate finance at institutions including UniCredit and Société Générale — managing a $450M loan portfolio and making senior partner at a major mezzanine lender by 29 — then built a fractional CFO firm exclusively for outpatient healthcare clinics.
Want to see how your practice measures up?
Take the 4-minute financial assessment. It is free, and it will show you where your practice is leaking money.